SLAS Scientific Manager Hannah Rosen, PhD is joined by Sapient Founder and CEO Mo Jain, MD, PhD, for an insightful discussion on small molecule biomarkers. Did you know that methods of utilizing small molecule biomarkers for diagnostics date all the way back to ancient Greece? Listen to hear how, along with the many ways these biomarkers are shaping drug discovery and other applications today. Dr. Jain also shares his background and what led to him to creating Sapient along with the company’s own next-generation mass spectrometry-based technology platform used for biomarker discovery at scale.

Listen above or by searching “New Matter” in your favorite podcast platform!